Informazioni sul prodotto
BMS 566419 is a calcineurin inhibitor that has been approved for the treatment of multiple sclerosis. It is also used to prevent organ rejection in transplant patients who have received a new heart, kidney, or liver. BMS 566419 has been shown to inhibit the production of hydroxyproline and collagen by inhibiting the activity of inosine monophosphate dehydrogenase. This drug is taken orally and shows dose-dependent pharmacokinetic properties. The pharmacokinetic profile of this drug can be influenced by other drugs that are also metabolized by CYP3A4 enzymes (e.g., cyclosporin A).
Proprietà chimiche
Richiesta tecnica su: 3D-RXA16124 BMS 566419
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.